Jazz Pharmaceuticals (NASDAQ:JAZZ) reported its Q1 earnings results on Wednesday, May 4, 2022 at 05:05 PM.
Here's what investors need to know about the announcement.
Earnings
Jazz Pharmaceuticals missed estimated earnings by 2.61%, reporting an EPS of $3.73 versus an estimate of $3.83.
Revenue was up $206.14 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.58 which was followed by a 12.05% increase in the share price the next day.
Here's a look at Jazz Pharmaceuticals's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | 3.63 | 3.31 | 3.42 | 3.74 |
| EPS Actual | 4.21 | 4.20 | 3.90 | 3.92 |
| Revenue Estimate | 865.88M | 832.52M | 735.62M | 611.49M |
| Revenue Actual | 896.73M | 838.12M | 751.81M | 607.58M |
To track all earnings releases for Jazz Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
